The treatment of advanced sinonasal malignancies with pre-operative intra-arterial cisplatin and concurrent radiation

Lattimore Michael, Jeffrey Sorenson, Sandeep Samant, Jon H. Robertson

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Introduction: Malignancies of the nasal and paranasal sinuses are uncommon tumors, accounting for only 3% of all aerodigestive tract neoplasms. Despite advances in surgical techniques and continued evolution of adjuvant therapies, the 5-year mortality remains unusually high at greater than 50%. In 1996, we begin utilizing a novel strategy in the treatment of advanced sinonasal carcinomas. This consisted of neoadjuvant selective intra-arterial cisplatin with concurrent radiation therapy (acronym RADPLAT) followed by a conservative craniofacial resection. We now report our results for 11 patients treated with this regimen. Methods: Between July 1996 and April 2003, 11 patients with advanced sinonasal malignancies underwent treatment utilizing the RADPLAT protocol followed by a planned surgical resection via a craniofacial approach. Patient charts, operative notes, follow-up clinic notes, and pre- and post-operative imaging studies were reviewed in detail for each subject. Results: Histopathological analysis of the tumors revealed seven squamous cell carcinomas (64%), two adenocarcinomas (18%), one adenoid cystic carcinoma (9%), and one sinonasal undifferentiated carcinoma (9%). T4N0M0 disease was present in nine patients (81%), and two patients had T3N0M0 disease (19%). Survival was calculated using the Kaplan-Meier method with an overall survival of 81% at 5 years and a progression-free survival at 5 years of 67%. Mean follow-up is 57.2 months ranging from 12 to 95 months. Conclusions: The treatment of advanced sinonasal malignancies with pre-operative intra-arterial cisplatin and concurrent radiation results in a significant improvement in survival. This can be done safely with high response rates and excellent loco-regional control in T3 and T4 disease. Although are results are encouraging, there is a need for a cooperative, multi-institutional, prospective study.

Original languageEnglish (US)
Pages (from-to)67-75
Number of pages9
JournalJournal of Neuro-Oncology
Volume72
Issue number1
DOIs
StatePublished - Mar 1 2005

Fingerprint

Cisplatin
Radiation
Neoplasms
Paranasal Sinuses
Survival
Therapeutics
Adenoid Cystic Carcinoma
Disease-Free Survival
Squamous Cell Carcinoma
Adenocarcinoma
Radiotherapy
Prospective Studies
Carcinoma
Mortality

All Science Journal Classification (ASJC) codes

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this

The treatment of advanced sinonasal malignancies with pre-operative intra-arterial cisplatin and concurrent radiation. / Michael, Lattimore; Sorenson, Jeffrey; Samant, Sandeep; Robertson, Jon H.

In: Journal of Neuro-Oncology, Vol. 72, No. 1, 01.03.2005, p. 67-75.

Research output: Contribution to journalArticle

@article{3dead18c02f440ce91c13e28db20c609,
title = "The treatment of advanced sinonasal malignancies with pre-operative intra-arterial cisplatin and concurrent radiation",
abstract = "Introduction: Malignancies of the nasal and paranasal sinuses are uncommon tumors, accounting for only 3{\%} of all aerodigestive tract neoplasms. Despite advances in surgical techniques and continued evolution of adjuvant therapies, the 5-year mortality remains unusually high at greater than 50{\%}. In 1996, we begin utilizing a novel strategy in the treatment of advanced sinonasal carcinomas. This consisted of neoadjuvant selective intra-arterial cisplatin with concurrent radiation therapy (acronym RADPLAT) followed by a conservative craniofacial resection. We now report our results for 11 patients treated with this regimen. Methods: Between July 1996 and April 2003, 11 patients with advanced sinonasal malignancies underwent treatment utilizing the RADPLAT protocol followed by a planned surgical resection via a craniofacial approach. Patient charts, operative notes, follow-up clinic notes, and pre- and post-operative imaging studies were reviewed in detail for each subject. Results: Histopathological analysis of the tumors revealed seven squamous cell carcinomas (64{\%}), two adenocarcinomas (18{\%}), one adenoid cystic carcinoma (9{\%}), and one sinonasal undifferentiated carcinoma (9{\%}). T4N0M0 disease was present in nine patients (81{\%}), and two patients had T3N0M0 disease (19{\%}). Survival was calculated using the Kaplan-Meier method with an overall survival of 81{\%} at 5 years and a progression-free survival at 5 years of 67{\%}. Mean follow-up is 57.2 months ranging from 12 to 95 months. Conclusions: The treatment of advanced sinonasal malignancies with pre-operative intra-arterial cisplatin and concurrent radiation results in a significant improvement in survival. This can be done safely with high response rates and excellent loco-regional control in T3 and T4 disease. Although are results are encouraging, there is a need for a cooperative, multi-institutional, prospective study.",
author = "Lattimore Michael and Jeffrey Sorenson and Sandeep Samant and Robertson, {Jon H.}",
year = "2005",
month = "3",
day = "1",
doi = "10.1007/s11060-004-2712-0",
language = "English (US)",
volume = "72",
pages = "67--75",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - The treatment of advanced sinonasal malignancies with pre-operative intra-arterial cisplatin and concurrent radiation

AU - Michael, Lattimore

AU - Sorenson, Jeffrey

AU - Samant, Sandeep

AU - Robertson, Jon H.

PY - 2005/3/1

Y1 - 2005/3/1

N2 - Introduction: Malignancies of the nasal and paranasal sinuses are uncommon tumors, accounting for only 3% of all aerodigestive tract neoplasms. Despite advances in surgical techniques and continued evolution of adjuvant therapies, the 5-year mortality remains unusually high at greater than 50%. In 1996, we begin utilizing a novel strategy in the treatment of advanced sinonasal carcinomas. This consisted of neoadjuvant selective intra-arterial cisplatin with concurrent radiation therapy (acronym RADPLAT) followed by a conservative craniofacial resection. We now report our results for 11 patients treated with this regimen. Methods: Between July 1996 and April 2003, 11 patients with advanced sinonasal malignancies underwent treatment utilizing the RADPLAT protocol followed by a planned surgical resection via a craniofacial approach. Patient charts, operative notes, follow-up clinic notes, and pre- and post-operative imaging studies were reviewed in detail for each subject. Results: Histopathological analysis of the tumors revealed seven squamous cell carcinomas (64%), two adenocarcinomas (18%), one adenoid cystic carcinoma (9%), and one sinonasal undifferentiated carcinoma (9%). T4N0M0 disease was present in nine patients (81%), and two patients had T3N0M0 disease (19%). Survival was calculated using the Kaplan-Meier method with an overall survival of 81% at 5 years and a progression-free survival at 5 years of 67%. Mean follow-up is 57.2 months ranging from 12 to 95 months. Conclusions: The treatment of advanced sinonasal malignancies with pre-operative intra-arterial cisplatin and concurrent radiation results in a significant improvement in survival. This can be done safely with high response rates and excellent loco-regional control in T3 and T4 disease. Although are results are encouraging, there is a need for a cooperative, multi-institutional, prospective study.

AB - Introduction: Malignancies of the nasal and paranasal sinuses are uncommon tumors, accounting for only 3% of all aerodigestive tract neoplasms. Despite advances in surgical techniques and continued evolution of adjuvant therapies, the 5-year mortality remains unusually high at greater than 50%. In 1996, we begin utilizing a novel strategy in the treatment of advanced sinonasal carcinomas. This consisted of neoadjuvant selective intra-arterial cisplatin with concurrent radiation therapy (acronym RADPLAT) followed by a conservative craniofacial resection. We now report our results for 11 patients treated with this regimen. Methods: Between July 1996 and April 2003, 11 patients with advanced sinonasal malignancies underwent treatment utilizing the RADPLAT protocol followed by a planned surgical resection via a craniofacial approach. Patient charts, operative notes, follow-up clinic notes, and pre- and post-operative imaging studies were reviewed in detail for each subject. Results: Histopathological analysis of the tumors revealed seven squamous cell carcinomas (64%), two adenocarcinomas (18%), one adenoid cystic carcinoma (9%), and one sinonasal undifferentiated carcinoma (9%). T4N0M0 disease was present in nine patients (81%), and two patients had T3N0M0 disease (19%). Survival was calculated using the Kaplan-Meier method with an overall survival of 81% at 5 years and a progression-free survival at 5 years of 67%. Mean follow-up is 57.2 months ranging from 12 to 95 months. Conclusions: The treatment of advanced sinonasal malignancies with pre-operative intra-arterial cisplatin and concurrent radiation results in a significant improvement in survival. This can be done safely with high response rates and excellent loco-regional control in T3 and T4 disease. Although are results are encouraging, there is a need for a cooperative, multi-institutional, prospective study.

UR - http://www.scopus.com/inward/record.url?scp=21244506221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21244506221&partnerID=8YFLogxK

U2 - 10.1007/s11060-004-2712-0

DO - 10.1007/s11060-004-2712-0

M3 - Article

VL - 72

SP - 67

EP - 75

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -